123 related articles for article (PubMed ID: 30844721)
1. CUEDC2: multifunctional roles in carcinogenesis.
Xiao JB; Leng AM; Zhang YQ; Wen Z; He J; Ye GN
Front Biosci (Landmark Ed); 2019 Mar; 24(5):935-946. PubMed ID: 30844721
[TBL] [Abstract][Full Text] [Related]
2. CUEDC2: an emerging key player in inflammation and tumorigenesis.
Man J; Zhang X
Protein Cell; 2011 Sep; 2(9):699-703. PubMed ID: 21976060
[TBL] [Abstract][Full Text] [Related]
3. CUEDC2 suppresses glioma tumorigenicity by inhibiting the activation of STAT3 and NF-κB signaling pathway.
Li F; Tang C; Jin D; Guan L; Wu Y; Liu X; Wu X; Wu QY; Gao D
Int J Oncol; 2017 Jul; 51(1):115-127. PubMed ID: 28534933
[TBL] [Abstract][Full Text] [Related]
4. CUEDC2 down-regulation is associated with tumor growth and poor prognosis in lung adenocarcinoma.
Sun L; Bai L; Lin G; Wang R; Liu Y; Cai J; Guo Y; Zhu Z; Xie C
Oncotarget; 2015 Aug; 6(24):20685-96. PubMed ID: 26023733
[TBL] [Abstract][Full Text] [Related]
5. Cdk1-phosphorylated CUEDC2 promotes spindle checkpoint inactivation and chromosomal instability.
Gao YF; Li T; Chang Y; Wang YB; Zhang WN; Li WH; He K; Mu R; Zhen C; Man JH; Pan X; Li T; Chen L; Yu M; Liang B; Chen Y; Xia Q; Zhou T; Gong WL; Li AL; Li HY; Zhang XM
Nat Cell Biol; 2011 Jul; 13(8):924-33. PubMed ID: 21743465
[TBL] [Abstract][Full Text] [Related]
6. CUE domain-containing protein 2 promotes the Warburg effect and tumorigenesis.
Zhong X; Tian S; Zhang X; Diao X; Dong F; Yang J; Li Z; Sun L; Wang L; He X; Wu G; Hu X; Wang L; Song L; Zhang H; Pan X; Li A; Gao P
EMBO Rep; 2017 May; 18(5):809-825. PubMed ID: 28325773
[TBL] [Abstract][Full Text] [Related]
7. Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1.
Li HY; Liu H; Wang CH; Zhang JY; Man JH; Gao YF; Zhang PJ; Li WH; Zhao J; Pan X; Zhou T; Gong WL; Li AL; Zhang XM
Nat Immunol; 2008 May; 9(5):533-41. PubMed ID: 18362886
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer.
Pan X; Zhou T; Tai YH; Wang C; Zhao J; Cao Y; Chen Y; Zhang PJ; Yu M; Zhen C; Mu R; Bai ZF; Li HY; Li AL; Liang B; Jian Z; Zhang WN; Man JH; Gao YF; Gong WL; Wei LX; Zhang XM
Nat Med; 2011 Jun; 17(6):708-14. PubMed ID: 21572428
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of the miR-324-5p-CUEDC2 axis leads to macrophage dysfunction and is associated with colon cancer.
Chen Y; Wang SX; Mu R; Luo X; Liu ZS; Liang B; Zhuo HL; Hao XP; Wang Q; Fang DF; Bai ZF; Wang QY; Wang HM; Jin BF; Gong WL; Zhou T; Zhang XM; Xia Q; Li T
Cell Rep; 2014 Jun; 7(6):1982-93. PubMed ID: 24882011
[TBL] [Abstract][Full Text] [Related]
10. Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis.
Song L; Liu D; Zhao Y; He J; Kang H; Dai Z; Wang X; Zhang S; Zan Y
Biochem Biophys Res Commun; 2015 Aug; 464(3):705-10. PubMed ID: 26166821
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ADAM19 and CUEDC2 expression in EHCC and their clinicopathological significance.
Xu S; Huang S; Li D; Zou Q; Yuan Y; Yang Z
Biomark Med; 2020 Nov; 14(16):1573-1584. PubMed ID: 32960074
[No Abstract] [Full Text] [Related]
12. [Expression of fascin and CK14 in different histological types of cancer and its differential diagnostic significance].
Xue LY; Zou SM; Zheng S; Xie YQ; Wen P; Liu XY; Lin DM; Lü N
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):838-44. PubMed ID: 21223690
[TBL] [Abstract][Full Text] [Related]
13. CUEDC2 sensitizes chronic myeloid leukemic cells to imatinib treatment.
Zhang H; Chang G; Wang J; Lin Y; Ma L; Pang T
Leuk Res; 2013 Nov; 37(11):1583-91. PubMed ID: 24125838
[TBL] [Abstract][Full Text] [Related]
14. CUEDC2 (CUE domain-containing 2) and SOCS3 (suppressors of cytokine signaling 3) cooperate to negatively regulate Janus kinase 1/signal transducers and activators of transcription 3 signaling.
Zhang WN; Wang L; Wang Q; Luo X; Fang DF; Chen Y; Pan X; Man JH; Xia Q; Jin BF; Li WH; Li T; Liang B; Chen L; Gong WL; Yu M; Li AL; Zhou T; Li HY
J Biol Chem; 2012 Jan; 287(1):382-392. PubMed ID: 22084247
[TBL] [Abstract][Full Text] [Related]
15. CUEDC2 Protects Against Experimental Colitis and Suppresses Excessive Proliferation of Intestinal Mucosa.
Wang S; Pu J; Li N; Li C; Li C; Yu L; Wang X; Fu S; Cui L
Dig Dis Sci; 2015 Dec; 60(12):3603-9. PubMed ID: 26182901
[TBL] [Abstract][Full Text] [Related]
16. CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome.
Zhang PJ; Zhao J; Li HY; Man JH; He K; Zhou T; Pan X; Li AL; Gong WL; Jin BF; Xia Q; Yu M; Shen BF; Zhang XM
EMBO J; 2007 Apr; 26(7):1831-42. PubMed ID: 17347654
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-324-5p-CUEDC2 Axis Mediates Gain-of-Function Mutant p53-Driven Cancer Stemness.
Ghatak D; Datta A; Roychowdhury T; Chattopadhyay S; Roychoudhury S
Mol Cancer Res; 2021 Oct; 19(10):1635-1650. PubMed ID: 34257080
[TBL] [Abstract][Full Text] [Related]
18. Expression of CUEDC2 in colorectal cancer with different invasion and migration abilities.
Hu S; Hu Z; Li S; He C; Wu Y; Teng D; Yan Y; Li H; Xing X; Zou G; Li Y; Yang Y; Wang Y; Du X
J Int Med Res; 2019 Feb; 47(2):905-914. PubMed ID: 30651016
[TBL] [Abstract][Full Text] [Related]
19. CUEDC2 interacts with heat shock protein 70 and negatively regulates its chaperone activity.
Gong L; Wang CH; Huang YJ; Liu F; Li T; Dai J; Li AL; Zhou T; Xia Q; Chen L
Biochem Biophys Res Commun; 2014 Apr; 447(1):64-9. PubMed ID: 24685480
[TBL] [Abstract][Full Text] [Related]
20. Down-Regulated CUEDC2 Increases GDNF Expression by Stabilizing CREB Through Reducing Its Ubiquitination in Glioma.
Liu XF; Tang CX; Zhang L; Tong SY; Wang Y; Abdulrahman AA; Ji GQ; Gao Y; Gao DS; Zhang BL
Neurochem Res; 2020 Dec; 45(12):2915-2925. PubMed ID: 33125618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
